• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC ENTERPRISE2 4MMX30MM NO TIP; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC ENTERPRISE2 4MMX30MM NO TIP; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number ENF403000
Medical Device Problem Codes Premature Activation (1484); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 07/19/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Concomitant med products due to character limitation: 6f sheath, 6f envoy guiding catheter, axium (medtronic) coils.Initial reporter - the customer contact information, including occupation, phone, and fax number, was not reported.Complaint conclusion: as reported by a healthcare professional, during a stent-assisted coil embolization of a recurrent mildly tortuous left ophthalmic artery aneurysm, the 4 mm x 30 mm enterprise 2 no tip (enf403000/10689189) stent was loaded, flushed, and advanced through the 0.021¿ rapid transit 150 cm (601251x/30042646) dual marker microcatheter, but resistance was encountered about halfway through the microcatheter and the stent could no longer be advanced.The stent became stuck in the microcatheter hub during removal; therefore, the microcatheter was removed from the patient.The microcatheter and stent were replaced, and target position was easily re-obtained.The enterprise 2 stent was implanted across the neck of the aneurysm and four competitor coils were placed in the aneurysm.Post angiography revealed good result and the case was concluded.No patient complications occurred as a result of the event.The surgery was delayed 5-10 minutes due to the event.The patient did well post-op and was discharged the following day.The right femoral artery was accessed with a 6f sheath.The target aneurysm was previously coiled with competitor coils.No visible product damage was noted prior to the event.An adequate continuous flush was maintained through the catheter.There was no difficulty encountered during introduction of the catheter over the guidewire prior to the attempted use of the device.A 6f envoy guiding catheter was used in the case.No further information was provided.A non-sterile enterprise2 4 mm x 30 mm no tip and rapidtransit dual marker 150 cm microcatheter were received inside of a pouch.The delivery wire was inspected, and no damage was observed.The introducer was not returned for evaluation.The stent was found deployed in the hub of the microcatheter.The stent was removed from the microcatheter hub and no damage was noted to the stent.No additional damage was observed.Functional testing could not be performed since the introducer was not returned for evaluation and the stent was found deployed in the microcatheter hub.Although the stent was removed from the microcatheter, per procedure, the stent must still be inside of the introducer tube to perform functional examination.A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection process that can be related to the reported complaint.The reported customer complaint ¿delivery wire- impeded in microcatheter with loss of cerebral target position¿ could not be evaluated since the introducer was not returned and is needed to perform functional testing with the microcatheter.The reported complaint of ¿stent deployment difficulty-premature/in microcatheter hub" was confirmed since the stent was found deployed in the hub of the microcatheter.Impeded in microcatheter and premature deployment are known potential issues associated with the enterprise 2 stent.The instructions for use (ifu) contains several cautions relating to this situation, including instructions for troubleshooting the situation should it be encountered during use.The device did not present any obvious indication of manufacturing defect or anomaly that could have contributed to the event as reported.Neither the product analysis nor the device history review suggests that the failure could be related to the manufacturing process of the unit.Assignment of root cause for the event remains speculative and inconclusive, based on the information provided and the evidence presented by the sample article; however, it is possible that procedural and handling factors may have contributed to the reported failure.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective/preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.This is one of two products involved with the reported complaint and the associated manufacturer report numbers are 1226348-2018-00734.
 
Event or Problem Description
As reported by a healthcare professional, during a stent-assisted coil embolization of a recurrent left ophthalmic artery aneurysm, the 4 mm x 30 mm enterprise 2 no tip (enf403000/10689189) stent was loaded, flushed, and advanced through the 0.021¿ rapid transit 150 cm (601251x/30042646) dual marker microcatheter, but resistance was encountered about halfway through the microcatheter and the stent could no longer be advanced.The stent became stuck in the microcatheter hub during removal; therefore, the microcatheter was removed from the patient.The microcatheter and stent were replaced, and target position was easily re-obtained.The enterprise 2 stent was implanted across the neck of the aneurysm and four competitor coils were placed in the aneurysm.Post angiography revealed good result and the case was concluded.No patient complications occurred as a result of the event.The surgery was delayed 5-10 minutes due to the event.The patient did well post-op and was discharged the following day.The right femoral artery was accessed with a 6f sheath.The target aneurysm was previously coiled with competitor coils one year prior.The vessel tortuosity was low.No visible product damage was noted prior to the event.An adequate continuous flush was maintained through the catheter.There was no difficulty encountered during introduction of the catheter over the guidewire prior to the attempted use of the device.A 6f envoy guiding catheter and the rapid transit microcatheter were advanced past the coiled aneurysm for stent placement, but the enterprise became stuck in the microcatheter.Photo provided by the sales representative appears to confirm the stent stuck in the hub of the microcatheter.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERPRISE2 4MMX30MM NO TIP
Common Device Name
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
MDR Report Key7876761
Report Number1226348-2018-00733
Device Sequence Number2217636
Product Code NJE
UDI-Device Identifier10886704075387
UDI-Public10886704075387
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
H60001
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/28/2019
Device Catalogue NumberENF403000
Device Lot Number10689189
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/29/2018
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/04/2018
Initial Report FDA Received Date09/14/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age27 YR
Patient Weight113
-
-